Exscientia
ignite phase initiated in | Exscientia
Company
Deck Type
Sector
Industry
Deck date
August 2023
Slide
31 of 75
Similar slides by Exscientia
See diffirences between slides (animation)
Investor Presentation
March 2024
elucidate phase ongoing in advanced solid | Exscientia
Results
March 2024
elucidate phase ongoing in advanced solid | Exscientia
Investor Day
January 2024
elucidate phase ongoing in advanced solid | Exscientia
Investor Presentation
November 2023
elucidate phase ongoing in advanced solid | Exscientia
Related slides by other companies
Nuvalent
Investor Presentation
January 2024
the path to patient impact ams program status first approved and pivotal data study for phase ongoing with registrational intent for patients with execute on global registrational strategies additional discovery research programs ongoing product study for alk demonstrated clinical proof of concept in phase with mission bringing new best in class medicines to patients with cancer planned development in both and alk planned phase initiation in for her i | Nuvalent
BioAtla
Investor Presentation
January 2024
cab phase dose titration ongoing | BioAtla
AstraZeneca
Results
February 2025
significant progress with transformative technologies to drive growth | AstraZeneca
BioNTech
Results
November 2021
phase pharmacodynamic effects consistent with proposed mechanism of action in patients with who progressed on therapy | BioNTech
Other recent decks by Exscientia
See all presentations (14 decks)
Investor Presentation
March 2024
Results
March 2024
Investor Day
January 2024
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights